Holen Sie sich die Stockscreener-App
660.49
3.29%
21.06
Handel nachbörslich:
662.86
2.37
+0.36%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LLY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Lilly Eli Co Aktie (LLY) Neueste Nachrichten
Texas Sues Eli Lilly: 'Big Pharma Compromised Medical Decision-Making' - Law.com
Jacob van Naarden, Lilly Oncology president, buys $647k in LLY stock - Investing.com
Why Eli Lilly Stock Popped Today - AOL.com
Fund Update: Haverford Trust Co added 38,232 shares of ELI LILLY (LLY) to their portfolio - Quiver Quantitative
Eli Lilly First to Use Germany’s New Confidential Pricing for Mounjaro - Insider Monkey
Jim Cramer on Eli Lilly Stock: “It Just Got Pole-Axed, Laid to Waste” - Insider Monkey
Eli Lilly's $5.9B Houston manufacturing site gets first green light from Texas comptroller - The Business Journals
Why Eli Lilly Stock Popped Today - The Motley Fool
Texas AG sues Eli Lilly over alleged kickbacks as pharma giant eyes $5.9B Houston investment - The Business Journals
Time to Buy Eli Lilly and Other Undervalued Healthcare Stocks? - Yahoo Finance
Lilly launches Mounjaro pen in India at $160 for starting dose, stepping up Novo rivalry - Reuters
LLY: Eli Lilly Stock Tanks -- Insiders Rush In With Millions - TradingView
Texas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound - AOL.com
Eli Lilly stock price target lowered to $825 by Cantor Fitzgerald - Investing.com Nigeria
Eli Lilly (LLY) Expands Mounjaro Availability with New Injector in India - GuruFocus
Texas Accuses Lilly of ‘Bribing’ Prescribers To Push Mounjaro, Zepbound in New Suit - BioSpace
Guggenheim lowers Eli Lilly stock price target on GLP-1 market uncertainty By Investing.com - Investing.com South Africa
Guggenheim lowers Eli Lilly stock price target on GLP-1 market uncertainty - Investing.com
Eli Lilly (LLY) Executives Capitalize on Stock Dip with Signific - GuruFocus
Eli Lilly stock rebounds after insider buying (LLY:NYSE) - Seeking Alpha
Eli Lilly launches Mounjaro KwikPen for diabetes treatment in India - The Economic Times
Novo Nordisk, Eli Lilly and Pfizer apply for inclusion in Chinese health insurance - medwatch.com
Eli Lilly's Mounjaro to land in Korea, setting off price war with Wegovy - Korea JoongAng Daily
Stock Analysis | Eli Lilly OutlookMixed Signals as Earnings Loom and Technicals Turn Cautious - AInvest
Eli Lilly Faces US Lawsuit Over Bribery Allegations - MarketScreener
Top Executives at Eli Lilly & Co Make Major Stock Purchases! - TipRanks
Texas Says Eli Lilly Offered Nursing Services As Kickbacks - Law360
Texas sues, accusing Eli Lilly of 'bribing' physicians to prescribe GLP-1s - Houston Chronicle
These Eli Lilly executives have been scooping up stock after its big drop - MarketWatch
Texas sues Eli Lilly for allegedly bribing providers to push weight loss medications - Dallas News
Texas AG sues Eli Lilly for allegedly bribing medical providers to prescribe Lilly drugs - IndyStar
Texas sues Eli Lilly & Co. for bribing providers to prescribe medications - WISH-TV
Eli Lilly Executives and Directors Engage in Significant Stock Transactions - TradingView
Eli Lilly pledges vigorous defense as Texas sues over alleged drug kickbacks - Fierce Pharma
Texas AG: Eli Lilly and Co. offered kickbacks to providers to prescribe blockbuster drugs - The Indiana Lawyer
Texas Accuses Eli Lilly of Inducing Providers to Prescribe Drugs - Bloomberg Government News
Eli Lilly: The Bears Have Spoken Loud And Clear (Upgrade) (NYSE:LLY) - Seeking Alpha
Texas sues Eli Lilly for allegedly bribing providers to prescribe its medications - Reuters
Texas Sues Eli Lilly (LLY) for Allegedly Bribing Doctors to Prescribe Its Drugs - TipRanks
Texas Sues Eli Lilly Over Bribery Allegations: Retail Focuses On Company’s Upbeat Performance By Stocktwits - Investing.com India
Texas Sues Eli Lilly Over Bribery Allegations: Retail Focuses On Company’s Upbeat Performance - Stocktwits
Eli Lilly Sued by Texas for Allegedly Bribing Providers to Prescribe Its Medications - MarketScreener
Eli Lilly's Legal Battles and the Future of Big Pharma's Profitability - AInvest
Eli Lilly sued in Texas suit over illegal kickbacks (LLY) - Seeking Alpha
Texas sues Eli Lilly for allegedly bribing providers to prescribe its medications By Reuters - Investing.com
Texas Sues Eli Lilly for Allegedly Bribing Providers to Prescribe Its Medications - U.S. News & World Report
Eli Lilly & Co. (LLY) sued by Texas for allegedly bribing providers to prescribe company's medications - StreetInsider
UK Government, Eli Lilly Partner To Target Obesity Health Gaps - inkl
1 Reason to Buy Eli Lilly (LLY) Stock - The Motley Fool
If You'd Invested $1,000 in Eli Lilly (LLY) Stock 5 Years Ago, Here's How Much You'd Have Today - Mitrade
Cramer Expects This FinTech To Reach $100, Upset With Eli Lilly: 'Come Back And Talk To Me' - Benzinga
Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (Aug 2025) - 24/7 Wall St.
3 ways the GLP-1 market has changed shape this year - Pharma Voice
Best Stock to Buy: Eli Lilly Stock vs. Novo Nordisk Stock - The Globe and Mail
US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche - Yahoo Finance
Eli Lilly, Pfizer Seek Spot in China Private Insurance Catalog - Bloomberg.com
Wall Street punishes Eli Lilly (LLY) over clinical trials, ignoring record milestones - Investorsobserver
Lilly’s Mounjaro Exhibits Heart Benefits In Type 2 Diabetes Landmark Trial - Insider Monkey
0.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):